leadf
logo-loader
viewTherma Bright Inc
(
TSX-V:THRMOTC:TBRIFFRA:JNX
)

Therma Bright Inc upgrades to the OTCQB while it advances its COVID-19 rapid antigen saliva test

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF, FRA:JNX) CEO Rob Fia tells Proactive the Toronto, Ontario-based group has recently upgraded to the OTCQB platform in the US, while it makes progress with its AcuVid™ COVID-19 Rapid Antigen Saliva Test.

The diagnostic and medical device technology company says upgrading to the QB gives the company more access to US investors. Most recently, it completed and submitted additional research and documentation requested by the FDA, to gain Emergency Use Authorization on its saliva test.

Quick facts: Therma Bright Inc

Follow
TSX-V:THRM

Price: 0.425 CAD

Market Cap: $92.95 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Proactive Presents a Livestream Event with Nextech AR Solutions

Proactive's Steve Darling presents a Livestream Chat with NextTech AR Solutions Joining the chat Evan Gappelberg - CEO and Founder Paul Duffy - President and Chairman of the Board Mirjana Prpa - AR Product Manager and Head of AI Division Baran Korkmaz - Founder of ARway

1 hour, 31 minutes ago

2 min read